By Startup Story Team
Boston-based AI startup LogicFlo AI has raised $2.7 million in seed funding to fuel its global expansion across the pharmaceutical, biotech, and medtech sectors. The funding round was led by Lightspeed, with participation from a select group of investors focused on healthcare and enterprise AI.
Founded by Udith Vaidyanathan and Arun Ramakrishnan, LogicFlo AI is building a next-generation platform that reimagines how scientific work gets done in highly regulated industries like life sciences. Instead of replacing human experts, the company is taking a unique approach by creating intelligent AI agents that work under human supervision—a system designed to boost productivity without compromising accuracy, compliance, or control.
The company’s AI platform is already in production across several major life sciences firms worldwide, including a Fortune 500 client currently under contract. Early results have been nothing short of transformative: medical writing processes that typically take weeks have been shortened to just a few minutes, while medical information response times have dropped from nearly two weeks to just two days.
With this new funding, LogicFlo AI plans to accelerate product development, deepen integrations with key life sciences platforms such as Veeva and IQVIA, and scale its technical and go-to-market teams to meet the surging demand from the industry.
Talking about their vision, Udith Vaidyanathan, Co-founder and CEO, said:
“We are at a once-in-a-generation inflection point. For the first time, AI agents are capable of delivering meaningful productivity gains in regulated scientific work-not just possible, but inevitable. Unlike most automation tools, which try to replace people, LogicFlo AI is built to work with people. We want to empower life sciences professionals to focus on what only they can do-advancing medical science and raising the standard of care.“
Echoing this vision, Arun Ramakrishnan, Co-founder and CTO, added:
“Traditional automation has failed this sector because it’s too rigid and out of sync with how experts actually work. Our AI agents are not just smart-they’re flexible, scalable, and deeply aware of the scientific context they operate in.“
Rohil Bagga, VP of Investments at Lightspeed, expressed confidence in the team and the mission:
We’re excited to back LogicFlo AI as they redefine how life sciences and biotech organizations function. Their platform is enabling medical and commercial teams to build intelligent, agent-powered workflows that can dramatically enhance productivity. Udith and Arun bring the perfect mix of domain insight and technical brilliance-we’re proud to support them on this journey.
With this funding round, LogicFlo AI is all set to expand its footprint globally and continue enabling medical experts to work faster, smarter, and more effectively—marking a bold new chapter in AI-driven innovation for healthcare and life sciences.
